Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 493 to 500 of 500 entries
Sorted by: Best Match Show Resources per page
Phase I/II clinical trial of high-dose [.

European journal of nuclear medicine and molecular imaging

Kuroda R, Wakabayashi H, Araki R, Inaki A, Nishimura R, Ikawa Y, Yoshimura K, Murayama T, Imai Y, Funasaka T, Wada T, Kinuya S.
PMID: 34837510
Eur J Nucl Med Mol Imaging. 2021 Nov 27; doi: 10.1007/s00259-021-05630-7. Epub 2021 Nov 27.

TRIAL REGISTRATION NUMBER: jRCTs041180030.NAME OF REGISTRY: Feasibility of high-dose iodine-131-meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and haematopoietic stem cell transplantation (High-dose iodine-131-meta-iodobenzylguanidine therapy for high-risk neuroblastoma). URL OF REGISTRY: https://jrct.niph.go.jp/en-latest-detail/jRCTs041180030 .DATE OF ENROLMENT OF THE FIRST PARTICIPANT...

Cite
Kuroda R, Wakabayashi H, Araki R, et al. Phase I/II clinical trial of high-dose [. Eur J Nucl Med Mol Imaging. 2021;doi: 10.1007/s00259-021-05630-7.
Kuroda, R., Wakabayashi, H., Araki, R., Inaki, A., Nishimura, R., Ikawa, Y., Yoshimura, K., Murayama, T., Imai, Y., Funasaka, T., Wada, T., & Kinuya, S. (2021). Phase I/II clinical trial of high-dose [. European journal of nuclear medicine and molecular imaging, . https://doi.org/10.1007/s00259-021-05630-7
Kuroda, Rie, et al. "Phase I/II clinical trial of high-dose [." European journal of nuclear medicine and molecular imaging vol. (2021). doi: https://doi.org/10.1007/s00259-021-05630-7
Kuroda R, Wakabayashi H, Araki R, Inaki A, Nishimura R, Ikawa Y, Yoshimura K, Murayama T, Imai Y, Funasaka T, Wada T, Kinuya S. Phase I/II clinical trial of high-dose [. Eur J Nucl Med Mol Imaging. 2021 Nov 27; doi: 10.1007/s00259-021-05630-7. Epub 2021 Nov 27. PMID: 34837510.
Copy Download .nbib Format: NLM
Radiosynthesis and characterization of [.

European journal of nuclear medicine and molecular imaging

Lee SH, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH, Kim HW, Kim SB, Park HS, Kim K, Lee SY, Youn H, Lee BC, Kim SE.
PMID: 34783879
Eur J Nucl Med Mol Imaging. 2021 Nov 16; doi: 10.1007/s00259-021-05617-4. Epub 2021 Nov 16.

PURPOSE: Translocator protein 18-kDa (TSPO) positron emission tomography (PET) is a valuable tool to detect neuroinflammed areas in a broad spectrum of neurodegenerative diseases. However, the clinical application of second-generation TSPO ligands as biomarkers is limited because of the...

Cite
Lee SH, Denora N, Laquintana V, et al. Radiosynthesis and characterization of [. Eur J Nucl Med Mol Imaging. 2021;doi: 10.1007/s00259-021-05617-4.
Lee, S. H., Denora, N., Laquintana, V., Mangiatordi, G. F., Lopedota, A., Lopalco, A., Cutrignelli, A., Franco, M., Delre, P., Song, I. H., Kim, H. W., Kim, S. B., Park, H. S., Kim, K., Lee, S. Y., Youn, H., Lee, B. C., & Kim, S. E. (2021). Radiosynthesis and characterization of [. European journal of nuclear medicine and molecular imaging, . https://doi.org/10.1007/s00259-021-05617-4
Lee, Sang Hee, et al. "Radiosynthesis and characterization of [." European journal of nuclear medicine and molecular imaging vol. (2021). doi: https://doi.org/10.1007/s00259-021-05617-4
Lee SH, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH, Kim HW, Kim SB, Park HS, Kim K, Lee SY, Youn H, Lee BC, Kim SE. Radiosynthesis and characterization of [. Eur J Nucl Med Mol Imaging. 2021 Nov 16; doi: 10.1007/s00259-021-05617-4. Epub 2021 Nov 16. PMID: 34783879.
Copy Download .nbib Format: NLM
Correction to: .

European journal of nuclear medicine and molecular imaging

Wang R, Liu Q, Sui H, Zhang M, Zhu Z, Cui R.
PMID: 33656579
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2064-2065. doi: 10.1007/s00259-021-05228-z.

No abstract available.

Cite
Wang R, Liu Q, Sui H, et al. Correction to: . Eur J Nucl Med Mol Imaging. 2021;48(6):2064-2065doi: 10.1007/s00259-021-05228-z.
Wang, R., Liu, Q., Sui, H., Zhang, M., Zhu, Z., & Cui, R. (2021). Correction to: . European journal of nuclear medicine and molecular imaging, 48(6), 2064-2065. https://doi.org/10.1007/s00259-021-05228-z
Wang, Rongxi, et al. "Correction to: ." European journal of nuclear medicine and molecular imaging vol. 48,6 (2021): 2064-2065. doi: https://doi.org/10.1007/s00259-021-05228-z
Wang R, Liu Q, Sui H, Zhang M, Zhu Z, Cui R. Correction to: . Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2064-2065. doi: 10.1007/s00259-021-05228-z. PMID: 33656579.
Copy Download .nbib Format: NLM
[No title available]

European journal of nuclear medicine and molecular imaging

Satapathy S, Mittal BR, Sood A, Das CK, Mavuduru RS, Goyal S, Shukla J, Singh SK.
PMID: 34842950
Eur J Nucl Med Mol Imaging. 2021 Nov 29; doi: 10.1007/s00259-021-05618-3. Epub 2021 Nov 29.

CLINICAL TRIAL REGISTRATION: Clinical Trials Registry-India, CTRI/2019/12/022282.

Cite
Satapathy S, Mittal BR, Sood A, et al. . Eur J Nucl Med Mol Imaging. 2021;doi: 10.1007/s00259-021-05618-3.
Satapathy, S., Mittal, B. R., Sood, A., Das, C. K., Mavuduru, R. S., Goyal, S., Shukla, J., & Singh, S. K. (2021). . European journal of nuclear medicine and molecular imaging, . https://doi.org/10.1007/s00259-021-05618-3
Satapathy, Swayamjeet, et al. "." European journal of nuclear medicine and molecular imaging vol. (2021). doi: https://doi.org/10.1007/s00259-021-05618-3
Satapathy S, Mittal BR, Sood A, Das CK, Mavuduru RS, Goyal S, Shukla J, Singh SK. . Eur J Nucl Med Mol Imaging. 2021 Nov 29; doi: 10.1007/s00259-021-05618-3. Epub 2021 Nov 29. PMID: 34842950; PMCID: PMC8627907.
Copy Download .nbib Format: NLM
Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of .

European journal of nuclear medicine and molecular imaging

Liu G, Yu H, Shi D, Hu P, Hu Y, Tan H, Zhang Y, Yin H, Shi H.
PMID: 34417855
Eur J Nucl Med Mol Imaging. 2021 Aug 21; doi: 10.1007/s00259-021-05500-2. Epub 2021 Aug 21.

PURPOSE: To investigate the performance of short-time dynamic imaging in quantifying kinetic metrics of 2-[METHODS: Dynamic total-body positron emission tomography (PET) imaging was performed in 11 healthy volunteers for 75 min. The data were divided into 30-, 45- and...

Cite
Liu G, Yu H, Shi D, et al. Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of . Eur J Nucl Med Mol Imaging. 2021;doi: 10.1007/s00259-021-05500-2.
Liu, G., Yu, H., Shi, D., Hu, P., Hu, Y., Tan, H., Zhang, Y., Yin, H., & Shi, H. (2021). Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of . European journal of nuclear medicine and molecular imaging, . https://doi.org/10.1007/s00259-021-05500-2
Liu, Guobing, et al. "Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of ." European journal of nuclear medicine and molecular imaging vol. (2021). doi: https://doi.org/10.1007/s00259-021-05500-2
Liu G, Yu H, Shi D, Hu P, Hu Y, Tan H, Zhang Y, Yin H, Shi H. Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of . Eur J Nucl Med Mol Imaging. 2021 Aug 21; doi: 10.1007/s00259-021-05500-2. Epub 2021 Aug 21. PMID: 34417855.
Copy Download .nbib Format: NLM
[.

European journal of nuclear medicine and molecular imaging

Cohen D, Luttwak E, Beyar-Katz O, Hazut Krauthammer S, Bar-On Y, Amit O, Gold R, Perry C, Avivi I, Ram R, Even-Sapir E.
PMID: 34480603
Eur J Nucl Med Mol Imaging. 2021 Sep 04; doi: 10.1007/s00259-021-05551-5. Epub 2021 Sep 04.

PURPOSE: The introduction of CD19-specific chimeric antigen receptor T-cell therapy (CAR-T) for treatment of relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) gives hope to patients with otherwise dismal prognosis. Therapy outcomes, however, depend upon selection of patients and...

Cite
Cohen D, Luttwak E, Beyar-Katz O, et al. [. Eur J Nucl Med Mol Imaging. 2021;doi: 10.1007/s00259-021-05551-5.
Cohen, D., Luttwak, E., Beyar-Katz, O., Hazut Krauthammer, S., Bar-On, Y., Amit, O., Gold, R., Perry, C., Avivi, I., Ram, R., & Even-Sapir, E. (2021). [. European journal of nuclear medicine and molecular imaging, . https://doi.org/10.1007/s00259-021-05551-5
Cohen, Dan, et al. "[." European journal of nuclear medicine and molecular imaging vol. (2021). doi: https://doi.org/10.1007/s00259-021-05551-5
Cohen D, Luttwak E, Beyar-Katz O, Hazut Krauthammer S, Bar-On Y, Amit O, Gold R, Perry C, Avivi I, Ram R, Even-Sapir E. [. Eur J Nucl Med Mol Imaging. 2021 Sep 04; doi: 10.1007/s00259-021-05551-5. Epub 2021 Sep 04. PMID: 34480603.
Copy Download .nbib Format: NLM
Correction to: High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results.

European journal of nuclear medicine and molecular imaging

Castellucci P, Savoia F, Farina A, Lima GM, Patrizi A, Baraldi C, Zagni F, Vichi S, Pettinato C, Morganti AG, Strigari L, Fanti S.
PMID: 33871669
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1706. doi: 10.1007/s00259-021-05363-7.

No abstract available.

Cite
Castellucci P, Savoia F, Farina A, et al. Correction to: High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results. Eur J Nucl Med Mol Imaging. 2021;48(5):1706doi: 10.1007/s00259-021-05363-7.
Castellucci, P., Savoia, F., Farina, A., Lima, G. M., Patrizi, A., Baraldi, C., Zagni, F., Vichi, S., Pettinato, C., Morganti, A. G., Strigari, L., & Fanti, S. (2021). Correction to: High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results. European journal of nuclear medicine and molecular imaging, 48(5), 1706. https://doi.org/10.1007/s00259-021-05363-7
Castellucci, Paolo, et al. "Correction to: High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results." European journal of nuclear medicine and molecular imaging vol. 48,5 (2021): 1706. doi: https://doi.org/10.1007/s00259-021-05363-7
Castellucci P, Savoia F, Farina A, Lima GM, Patrizi A, Baraldi C, Zagni F, Vichi S, Pettinato C, Morganti AG, Strigari L, Fanti S. Correction to: High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1706. doi: 10.1007/s00259-021-05363-7. PMID: 33871669; PMCID: PMC8182834.
Copy Download .nbib Format: NLM
Tissue dose estimation after extravasation of .

EJNMMI physics

Tylski P, Pina-Jomir G, Bournaud-Salinas C, Jalade P.
PMID: 33788043
EJNMMI Phys. 2021 Mar 31;8(1):33. doi: 10.1186/s40658-021-00378-3.

BACKGROUND: Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234-1243, 2017). Clinical management of these extravasations requires the preliminary estimation of the...

Cite
Tylski P, Pina-Jomir G, Bournaud-Salinas C, et al. Tissue dose estimation after extravasation of . EJNMMI Phys. 2021;8(1):33doi: 10.1186/s40658-021-00378-3.
Tylski, P., Pina-Jomir, G., Bournaud-Salinas, C., & Jalade, P. (2021). Tissue dose estimation after extravasation of . EJNMMI physics, 8(1), 33. https://doi.org/10.1186/s40658-021-00378-3
Tylski, Perrine, et al. "Tissue dose estimation after extravasation of ." EJNMMI physics vol. 8,1 (2021): 33. doi: https://doi.org/10.1186/s40658-021-00378-3
Tylski P, Pina-Jomir G, Bournaud-Salinas C, Jalade P. Tissue dose estimation after extravasation of . EJNMMI Phys. 2021 Mar 31;8(1):33. doi: 10.1186/s40658-021-00378-3. PMID: 33788043; PMCID: PMC8012450.
Copy Download .nbib Format: NLM
Showing 493 to 500 of 500 entries